Canadian pharmaceutical developer Draxis Health reported strong growth in revenues and net income for its second quarter (end-June 30).
For the period, the Mississauga, Ontario, company posted revenues of $20.5 million U.S., up 22% from the $16.7 million posted in the second quarter of 2004. The company's second-quarter net income was $2.4 million, compared with $100,000 in the corresponding quarter of 2004.
By AuntMinnie.com staff writers
August 11, 2005
Related Reading
Draxis joins Nasdaq biotech index, May 16, 2005
Draxis notches upbeat Q1, May 12, 2005
Draxis names president of radiopharmaceuticals group, April 27, 2005
Draxis begins Infecton trial, September 21, 2004
Draxis Health books record revenues, August 12, 2004
Copyright © 2005 AuntMinnie.com
